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Aflatoxin B1 (AFB1) is the most toxic in aflatoxin family. It is well known for 
its involvement in hepatic carcinogenesis. Other adverse effects include immune 
weakness, reproduction deficiency, malnutrition, and growth impairment. The key 
mechanism of AFB1 carcinogenesis is supposed to be epoxidation, which produce 
the AFB1-8,9-epoxide (AFBO) strongly adductive to DNA molecules. Other metab-
olites like AFM1, AFH1, and AFL, which retain DNA adductive capability, extend 
its toxicity. Scientists now found that AFB1 also affected epigenetic regulation, 
which might shed new light into AFB1 toxicity mechanism researches. The detoxi-
fication of AFB1 has always been a hot spot in AFB1-related studies. The major 
methods can be categorized into physical treatment, biological treatment, chemical 
treatment, combination strategy, and sorbent additives. None of the methods is 
100% perfect, however considering economic factors, simplicity, effectiveness, 
safety, and preservation of the food nutrition. This review will discuss the toxicity 
and toxic mechanisms of AFB1. Also, detoxification of AFB1 will be reviewed.
Keywords: AFB1, carcinogenesis, DNA adductive capability, epigenetic mutation, 
detoxification
1. Introduction
Aflatoxins are fungal metabolites majorly produced by Aspergillus flavus and  
A. parasiticus [1]. They are recognized as a family of toxic contaminants in a variety 
of crops, especially promoted by hot and humid climates as well as improper 
harvesting and storage process [2]. Among these toxins, aflatoxin B1 (AFB1) is 
the most hazardous, widely known for its “acute intoxication” targeting the liver 
featured by acute liver failure and death at a short yet high dosage exposure. Other 
major adverse effects include carcinogenicity and immunosuppression capacity in a 
chronic way.
2. Toxic effects of AFB1
AFB1 is well known to be hepatotoxic, causing degeneration and necrosis of the 
liver as well as proliferation of the bile duct and infiltration of inflammatory cells in 
many species. In recent studies, AFB1 is reported to lead to apoptosis of hepatocytes 
via an extrinsic mechanism because of high expression of death receptor pathway 
[3]. Moreover, in 2002, AFB1 has been classified into Group 1 of carcinogens, consid-
ering its direct contribution to hepatocellular carcinoma (HCC) [4]. In fact, as early 
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as in the 1970s, its hepatocarcinogenic property has been testified in animal models 
[5], and there since, several epidemiological studies from Asia and Africa areas mon-
itored intersection of high HCC incidence and AFB1 contamination, with 4.6–28.2% 
of HCC cases globally attributed to AFB1 exposure [6]. Moreover, hepatitis B virus 
(HBV) that cooperates with AFB1 can drastically increase the risk of HCC by 30-fold 
[7]. Recent researches also find evidences that hepatitis C virus (HCV) also has a 
synergistic role with AFB1 in hepatocarcinogenesis. Jeannot et al. found that the inci-
dence of tumorous or pretumorous lesions was elevated by 2.5-fold in AFB1-treated 
HCV transgenic mice compared with wild-type mice [8]. Recently, a 20-year clinical 
follow-up study in Taiwan investigated HCC risk associated with AFB1 exposure in 
HCV-positive and HBV-HCV-negative individuals. HCV and AFB1 exposure were 
both found as independent risk factors for HCC development. Elevated serum AFB1-
albumin adduct levels were significantly associated with an increased risk of HCC 
newly developed within 8 years of follow-up in non-HBV-non-HCV participants 
with habitual alcohol consumption [crude OR (95% CI) for high vs. low/undetect-
able levels, 4.22 (1.16–15.37)], and HCV-infected participants [3.39 (1.31–8.77)], but 
not in non-HBV-non-HCV participants without alcohol drinking habit. Therefore, it 
indicated that AFB1 exposure contributes to the development of HCC in participants 
with significant risk factors for cirrhosis including alcohol and HCV infection [9]. 
What’s more, AFB1 exposure can induce the increased levels of blood glucose in mice 
and, also, the high probability to develop liver cancer [10].
Liver is not the only target organ of AFB1 toxification. Its impairment on the 
immune system has been established in both humans and animals. Several studies 
linked AFB1 exposure with reduced levels or functions of immunological factors, 
such as decreased T or B lymphocyte activity [11, 12], suppressed macrophage or 
neutrophil effector functions [13], modified synthesis of inflammatory cytokines 
[14, 15], impaired NK cell-mediated cytolysis [16], and thus increasing risk to infec-
tious diseases. A study on Gambian children found that those children were gener-
ally exposed to high levels of aflatoxin (as much as 93%). The exposure significantly 
decreases sIgA in their saliva [17]. In another study, Jiang et al. reported that 
Ghanaians with higher serum aflatoxin-albumin adducts (AF-ALB) level had lower 
percentages of CD8+ T cells, perforin, and granzyme A than those with the lower 
level [18]. By comparing HIV-infected individuals exposed to high and low AF-ALB 
levels with HIV-negative counterparts, experts found that high AF-ALB appeared to 
accelerate HIV-associated changes in T-cell phenotypes and B cells in HIV-positive 
participants [19]. This result was in accordance with the observation of Hendrickse 
et al. long back in 1989 that heroin addicts often experienced rapid progression of 
HIV infection, while street heroin was often contaminated with aflatoxin and that 
aflatoxin derivatives were commonly found in the body fluids of the addicts [20]. 
Recent researches also show that when exposed to a low dose of AFB1, people were 
more vulnerable to SIV infection and suffered increased severity [21].
Another chronic adverse effect of AFB1 is malnutrition and growth impairment. 
Several observations in developing countries have pointed out the accordance of 
kwashiorkor occurrence with high AFB1 concentration in sera [22–24]. Animal mod-
els and in vitro methods have also been used to investigate the mechanism of AFB1-
induced malnutrition. AFB1 is supposed to alter metal absorption and bioavailability. 
Long back in the 1990s, broiler chicks exposed to AFB1 were found to have lowered 
serum concentrations of vitamin D and calcium possibly due to impairing renal 
function and altering parathyroid metabolism [25]. AFB1 had toxicity toward the 
vitamin D receptors, interfering with the actions of vitamin D on calcium-binding 
gene expression in the kidney and intestine, which increase the risk of rickets. 
Experimental data indicated a 58 and 86% decrease if the cells were exposed to 5 and 
50 ng/mL of AFB1, respectively [26]. Dietary intake of AFB1 also leads to vitamin A 
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depletion in young broiler chicks, which could be attenuated by additional feeding of 
NovaSil PLUS, an AFB1-binding agent [27]. Other adverse effects included inactivat-
ing enzymes in liver lipid metabolism [28] and redistribution of various metal ions in 
the central nervous system and genital glands [29]. Mechanistically, it is unclear how 
AFB1 alters nutrient levels. Existing hypothesis includes impairment of liver, absorp-
tion deficiency, and insulin-like growth factor modulation. Ubagai et al. found that 
AFB1 could modulate the insulin-like growth factor (IGF)-2 signaling axis [30]. 
Furthermore, Castelino et al. found that Kenyan schoolchildren that exhibited high 
levels of AFB1-albumin were shorter and had lower levels of IGF1 and IGFBP3 than 
groups with lower levels of the AFB1 biomarker [31]. Additionally, AFB1 may affect 
nutrient absorption through intestinal toxicity. Enteropathy features decreases in 
intestinal density and increases in fibrosis/necrosis, which has been shown in poultry 
experimental models [32]. The disruption of intestinal function by AFB1 is due to the 
destruction of epithelial cells and their organization due to the inhibition of protein 
synthesis or cytotoxicity due to DNA and protein binding. This tissue damage can 
alter the structure of intestinal epithelial cells, affecting the efficiency of nutrient 
absorption [33, 34]. Recent studies also found that lack of protein [35] and vitamins 
A, C, and E [36] together with aflatoxicosis worsened hepatic oxidative stress. These 
findings gave rise to the theory that toxification and malnutrition can form a vicious 
circle, which add up to the damage of AFB1.
AFB1 is not likely to be limited by the physical barrier. Aflatoxin metabolites and 
biomarkers can be tested in breastmilk and cord blood, which means this toxin can 
affect fetuses and neonates. Levels of aflatoxins in pregnant women have also been 
linked to poor birth outcomes in humans. An early Kenyan study indicated that 
newborns birthed from aflatoxin-positive mothers had significantly lower birth 
weights. The relation between AFB1 maternal exposure and growth impairment 
was significant and may even lead to stillbirth [37]. Another study found a strong 
negative correlation between aflatoxin levels and birth weights in Gambian infants 
[38]. Also, Shuaib et al. reported that mothers in the highest quartile of serum 
AFB1-albumin levels were highly likely to have lower birthrates than mothers with 
lower concentrations [39].
AFB1 not only interferes with the reproductive process after embryo forms. The 
findings of the current study repeatedly demonstrate direct effects of dietary toxin 
intaking on spermatozoa, oocytes, and in vitro fertilization while exploring the 
potential hazards associated with AFB1 exposure [40]. Low dose of AFB1 exposure 
was reported to cause follicular atresia in ovaries in animal models [41]. AFB1 was 
also testified to impair sperm quality and fertilization competence in animal and 
in vitro models, although the mechanism underlying cellular damage has not been 
fully elucidated. In summary the alterations include impairment of (1) membrane 
integrity, (2) mitochondrial function, (3) DNA integrity, and (4) fertilization com-
petence. Exposure of fresh semen to 10 μM AFB1 prefertilization resulted in sperm 
DNA damage and impaired fertilization competence, featured by reduced proportion 
of oocytes that are divided to early-stage embryos after fertilization [42]. Exposure of 
sperm to low concentrations of AFB1 for a few hours also resulted in decreased sperm 
viability and hyperpolarization of the mitochondrial membrane, which was most 
remarkable in ejaculated sperm, suggesting that later stages of spermatogenesis were 
affected. AFB1 may adversely affect the spermatogenesis through mitochondria-
dependent apoptosis via inducing oxidative stress, diminishing cellular mitochon-
drial content, and enhancing pro-apoptotic Bax, caspase-3, and p53 expression [43].
Besides all mentioned above, AFB1 also induces damage to the heart [44–46], 
kidney [45], and even central nervous systems by direct toxicity to both the neural 
cells and blood-brain barrier [47–49]. It is of great importance to better understand 
how this toxin functions in order to discriminate its threats to public health.
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3. The metabolism and toxic mechanism of AFB1
It is well established that AFB1 epoxidation is the key step in the genotoxic process 
leading to carcinogenesis. The predominant place of epoxidation is in the liver by the 
P450 family before transforming into the final carcinogen aflatoxin B1-8,9-epoxide 
(AFBO), which has two isomers: endo-8,9-epoxide and exo-8,9-epoxide [50]. 
CYP3A4 is the major producer of AFBO formation at high AFB1 concentrations, pro-
ducing primarily the exo isomer of AFBO [51], while lower concentration of AFB1 
exposure makes CYP1A2 the main producer of AFBO in turn. Additionally, CYP1A2 
was found to produce more of the exo isomer than CYP3A4 at these low concentra-
tions [52, 53]. The highly electrophilic nature of AFBO allows it to form adducts to 
amines in proteins or nucleic acids and then interrupt the function of these biological 
molecules. Since the exo isomer has a much higher affinity for guanine residues than 
the endo isomer, AFB1-exo-8,9 epoxide, which has the highest concentration in the 
liver, is therefore considered to be the major carcinogenic metabolite [54, 55].
AFB1 is also metabolized into a number of hydroxylation products through the 
P450 system. These include aflatoxin Q1 (AFQ1), aflatoxin P1 (AFP1), aflatoxin B2a 
(AFB2a), aflatoxin M1 (AFM1), aflatoxicol (AFL), and aflatoxicol H1 (AFH1), and 
among them, AFQ1, AFP1, and AFB2a were traditionally considered detoxification 
products of AFB1 due to their much lower DNA-binding potential [56–58]. In the 
recent decades, AFQ1 was found to have a potential as a biomarker for AFB1 expo-
sure indication. AFQ1 consists of 1–11% of the AFB1 hydroxylation products indicat-
ing that in humans, AFQ1 production occurs frequently and at high enough levels to 
detect [59]. In 2005, a study evaluated fecal and urinary excretion of AFM1, AFQ1, 
and AFB1-N7-guanine in 83 Chinese males. The study demonstrated that AFQ1 is 
excreted in urine and feces at higher levels than AFM1, especially in feces, since fecal 
samples contained approximately 60 times more AFQ1 than AFM1. Additionally, 
fecal concentrations of AFM1 and AFQ1 were higher than in urine, indicating the 
usefulness of feces as a predictive marker for AFB1 exposure [60]. However, as the 
most prominent metabolite of AFB1, AFB2a has an interesting property as compared 
to many of the other metabolites which has the ability to bind to cellular proteins 
through the formation of a pyrrole ring. Additionally, this binding only occurs on 
primary amines that is favored in alkaline pHs. This adduction can also occur on 
phosphoethanolamine head groups on phospholipids, forming a unique structurally 
characterized aflatoxin-lipid adduct [61]. The protein-binding capability of AFB2a 
is thought to contribute to other potential cellular toxicities. For example, AFB2a 
binding has been shown to inhibit the activity of deoxyribonucleases, demonstrating 
the ability of AFB2a to alter enzymatic activities of target proteins [62]. Chen et al. 
recently observed mitochondria-mediated apoptosis and PI3K/Akt/mTOR-mediated 
autophagy induced by AFB2 in hepatocytes of broilers [63]. AFB2a has been found 
in high levels in poultry eggs possibly as a result of avian metabolism, providing a 
potential source of dietary exposure [64]. AFM1 is a major metabolite produced 
by CYP1A2 and is the most carcinogenic of the hydroxylated metabolites. This is 
supported by the DNA-binding effect of AFM1 which has been demonstrated in rat, 
mouse, and pig and has even been identified to form an N7-guanine adduct similar 
to AFB1 [65]. Just like AFB1, AFM1 can be excreted in cattle or human milk [66]. 
AFM1 is also excreted in high levels in urine following AFB1 exposure and thus has 
become an additional biomarker of AFB1 exposure [67]. AFL is found in the cyto-
solic fractions of liver preparations and is formed by an NADPH reductase, usually 
in the cytosol [68, 69]. AFL retains its DNA-binding activity and has been shown 
to be enzymatically reconverted back into AFB1 acting as a reservoir for AFB1, 
extending its toxic effects [69]. Despite excretion in breast milk and urine, AFL is 
the sole metabolite that is able to be transferred through the human placenta, and, 
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furthermore, AFL is the only metabolite that is formed from AFB1 by the placenta 
itself. This indicates that AFL may play a large role in developmental toxicities 
of AFB1 [69]. AFH1 has a structure similar to AFL which contains an additional 
hydroxy group on the terminal cyclopentenone ring, which implies a similar toxic-
ity. The metabolic formation of AFH1 was found to be dependent on two enzyme 
systems: the microsomal hydroxylase and cytoplasmic reductase systems [70].
By firmly binding to purine bases (usually at the N7 position on guanine) of DNA, 
epoxide intermediate forms AFB1-N7-guanine (AFB1-N7-Gua) adduct, and thus 
promoting mutations in nucleotide sequence. The charged adduct causes depurination 
and thus apurinic site formation [71]. The predominant mutation caused by AFB1-N7-
Gua adduct has been identified to be the G → T transversion on the site of the original 
adduct [72]. Moreover, the mutation has a favor for specific base pair locations. Mace 
et al. reported a selective affinity for guanine bases with a guanine or a cytosine as 50 
bases and more specifically at the third base of codon 249 of the p53 tumor suppressor 
gene [73]. This mutation was found really common in a great number of epidemiolog-
ical studies on HCC patients from regions of high aflatoxin exposure, strengthening 
the association between HCC incidence and aflatoxin exposure [74].
Interestingly, AFB1 can be activated by other biotransformation aside from the 
principal pathway involving CYP. As early as in 1985, Battista et al. have described 
the epoxidation catalyzed by prostaglandin H (PGH) synthase [75], whereas Weng 
et al. hypothesized that lipid peroxidase (LPO) was one of the mechanisms behind 
AFB1 carcinogenesis, triggering the production of cyclic α-methyl-γ-hydroxy-1,N2-
propano-dG (meth-OH-PdG) adduct and inhibiting DNA repair [76]. Another 
important role in DNA damage and thus carcinogenesis is played by oxidative 
stress. A recent study showed that the AFB1 treatment resulted in a significant 
and concentration-dependent increase in intracellular ROS production, whereas 
mitochondrial functions such as glutamate/malate and succinate-driven respiration 
were significantly uncoupled. Those oxidative stress effects activated mitochondrial 
ROS-dependent signal pathways, which induced apoptosis through the mitochon-
drial signal pathway [77]. What’s more, there are some proteins modulated by AFB1 
like CYP1A2, CYP1A5, CYP3A4, TP53, GSMT1, MDM2, CAT, OGG1, IRS1, IRS2, 
SRC, AKT1, MAPK1, MAPK3, and PDK1. These proteins are involved in important 
metabolic pathways such as FoxO signaling pathway, PI3K-Akt signaling pathway, 
AMPK signaling pathway, MAPK signaling pathway, and VEGF signaling pathway 
[65]. In fact, those modulations induce both tumor progression and chemotherapy 
resistance as well as in other pathogenetic procedures.
To further investigate the mechanism behind nuclei damage, epigenetic changes 
cannot be omitted. Accumulating evidence also indicates that epigenetic modifica-
tions play a vital role in AFB1-induced carcinogenesis and more attention is being 
paid to them [78]. It is believed that epigenetic aberrations play important roles in 
tumorigenesis, pathways, and development of carcinogenesis including tumor inva-
sion, initiation, and plasticity [79, 80]. Those alterations include oncogene activa-
tion, tumor suppressor gene inactivation, and chromosomal instability (CIN), which 
then interfere with the critical signaling pathways. Epigenetic alterations include 
three kinds of modifications, DNA methylation, histone modifications, and regula-
tion of noncoding RNA (specifically small noncoding RNAs, microRNAs) [81, 82].
DNA methylation, which regulates the gene expression level, is one of the 
frequent epigenetic events in cancer development. The formation of AFB1 adducts 
is believed to cause methylation alteration of some important genes regulating 
the mutagenesis of AFB1 in the carcinogenetic development of HCC. In in vitro 
studies, Rieswijk investigated the persistent AFB1-induced impact on the DNA 
methylation footprint in relation to the transcriptome in HCC for the first time. 
By comparing the transcription level and DNA methylation degree, a number 
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of persistent hypomethylated and upregulated genes named PCNA, RAB27A, 
TXNRD1, DIAPH3, HIST1H2BF, and CCNK were identified to have an alteration 
on the transcriptome level. PCNA acts as a scaffold to recruit proteins involved in 
DNA replication and DNA repair including mismatch repair, cell cycle, apoptosis, 
chromatin remodeling, and preservation of epigenetic marks [83, 84]. RAB27A 
expression was closely correlated with tumor progression [85]. Upregulation 
of TXNRD1 decreases the expression of AFB1 aldehyde reductase (AFAR) and 
glutathione-S-transferase (GST) that are responsible for the detoxification of 
AFB1-8,9-epoxide via glutathione conjugation into less active metabolites, thereby 
promoting the formation of AFB1 adducts with macromolecules in the liver [86]. 
CCNK can bind with CDK12 to form the complex CCNK/CDK12 and regulate the 
expression of several DNA damage response genes and some critical regulators of 
genomic stability [87]. Moreover, Zhang et al. conducted a number of human stud-
ies about AFB1-induced methylation alterations in HCC. By investigating promoter 
methylation status in tumor suppressor and other cancer-related genes such as 
p16, RASSF1A [88], O6-methylguanine-DNA methyltransferase (MGMT) [89], 
glutathione-S-transferase p1 (GSTP1) [90], and the level of AFB1-DNA adducts in 
HCC tissue samples from Taiwan, they found that frequent aberrant methylation 
in the CpG islands of promoters of the genes mentioned above is closely related 
to hepatocarcinogenesis. In addition, the correlation between AFB1-DNA adducts 
and hypermethylation of these genes was found to be statistically significant. Since 
AFB1 plays an important role in the development of HCC, it can be speculated 
that AFB1 may bind preferentially to methylated CpG sites or specific structures 
in chromatin, inducing damage to DNA that may impact methylation [91]. 
Furthermore, according to the analysis of progression from the normal liver to HCC 
proposed by Herath et al. [92], under the aflatoxin exposure, methylation appears 
to precede cirrhosis in a subset of tumors, while tumors appear to be able to prog-
ress in the absence of cirrhosis, which may be a consequence of hypomethylation. 
The association between AFB1-DNA adducts and RASSF1A methylation in HCC 
was statistically significant. Multivariate analyses including the mRNA, protein 
expression, and methylation status of RASSF1A in HCC showed that RASSF1A 
hypermethylation was related to AFB1-DNA adducts. Besides, there seemed to be 
little effect of RASSF1A methylation on patient survival [93]. In whole-animal 
studies, Baik investigated the DNA methylation status of the rat gamma-glutamyl 
transpeptidase (GGT) gene in embryonic, adult, and neoplastic liver using rats 
treated with AFB1-contaminated peanuts in 1991. The methylation patterns of the 
GGT gene were investigated in AFB1-induced HCC tumors, and hypermethylation 
was observed. However, the regulatory mechanism of GGT methylation after AFB1 
exposure was not clear [94]. In addition, it was observed to be more than partial 
hypermethylation in the analyzed CpG sites of the p19Arf promoter, and methyla-
tion of transcription factor-binding sites or consensus sequences was confirmed in 
lung tumors of mice [95]. Wu assessed the relationship between AFB1 exposure and 
global DNA methylation. The methylation status of DNA in white blood cells from 
cancer-free participants was investigated through pyrosequencing, and the results 
showed that decreased Sat2 or LINE-1 methylation was associated with dietary 
exposure to AFB1, supporting the hypothesis that AFB1 might play an important 
role in HCC by altering the global DNA methylation status and that exposure to 
AFB1 induces global DNA hypomethylation [96] .
AFB1 exposure and DNA methylation are reported to be associated with 
embryonic development as well. In vivo, when pregnant women are exposed to 
AFB1, the DNA methylation status of their infants may be constantly influenced 
until 2–8 years old. Exposure to AFB1 gives rise to methylation alterations of some 
important genes including growth factor genes, such as IGF1 and FGF12, and 
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immune-related genes, TGFBI, TLR2, and CCL28 [97]. In vitro porcine models and 
oocyte exposure to AFB1 (50 μM) were revealed to appear increasing DNA methyla-
tion levels and oxidative stress, which may explain the excessive autophagy and 
apoptosis [98].
Histone, known as the chromatin-related protein, plays an important role in 
posttranslational modification. So, it is reasonable to speculate that AFB1-induced 
epigenetic mutation in histone is another mechanism of carcinogenesis. As early 
as in 1980, Groopman and Wogan used radiolabeled [3H] to mark the in vivo 
footprint of AFB1 residues in the rat liver. They observed that after 36 h of feeding 
marked AFB1, approximately 5–10% of the total nuclear-bound aflatoxin residues 
distributed in histones. Among all the histones, histone H1 was the major protein 
target for nuclear AFB1 binding, with an adduct level of three to four times higher 
than other companions [99]. Studies focusing on AFB1-induced reproductive 
toxicity also had a positive finding in histone. When investigating the relation-
ship between AFB1-induced epigenetic modifications and mammalian oocyte 
maturation, in 2015, Liu observed toxic epigenetic modifications in porcine oocyte 
of exposure to 50 μM AFB1. Results indicated that the levels of transcription 
marks H3K27me3 and H3K4me2 decreased, while the level of H3K9me3 increased 
[98]. H3K27me3 is responsible for silencing the expression of key developmental 
genes during embryonic stem cell differentiation [100]. H3K4me2/H3K4me3 and 
H3K9me3 are supposed to play an important role in the efficient reprogramming 
of pluripotency genes in somatic nuclei and thus determine cell fate [101, 102]. 
Another similar research study on mice gave up to the similar conclusion. Mice were 
fed with mycotoxin-contaminated maize and observed for histone change in their 
oocytes. According to the fluorescence intensity analysis, the levels of H4K20me3 
and H3K9me3 increased, while the levels of H4K20me2 and H3K27me3 decreased 
[103]. The results indicated that mycotoxins including AFB1 may improve the 
transcriptional activity of the oocyte genome by reducing the H3K27me3 levels and 
may affect the chromatin configuration and cell cycle progression in oocytes via 
altering the H3K9me3 levels, reducing H4K20me2 levels, and increasing H4K20me3 
levels. In addition, the DNA methylation level of oocyte in these two findings was 
both found to be increased. Ghufran et al. investigated AFB1-induced effects on an 
epigenetic regulatory protein, arginine methyltransferase 5 (PRMT5), in human 
cell lines for the first time in 2016 [104]. Upregulation of PRMT5 was observed after 
AFB1 treatment, which might play an important role in AFB1-induced tumorigen-
esis. However, the mechanism of upregulation of PRMT5 in AFB1-induced cancer 
remains obscure. Furthermore, besides histone methylation, AFB1 was also found 
to affect histone acetylation and deacetylation in the liver. Results showed that AFB1 
exposure increases the rate of deacetylation of histone fractions F2A1 and F3 [105].
MicroRNA (miRNA) is a kind of short-chain noncoding RNA which plays 
an important role in gene expression modulation. The previous research mainly 
focused on the regulation of miRNAs in AFB1-induced disease and tumorigen-
esis. In a study detecting the level of AFB1-DNA adducts and the expression of 
miRNA-429 [106] and miRNA-24 [107] in tumor tissues, miR-429 and miR-24 were 
found to be upregulated in HCC tumor tissues with high AFB1 exposure, and their 
high expression was significantly correlated with larger tumor size. Importantly, 
overexpression of these two miRNAs inhibits apoptosis, induces progression of 
tumor cell growth, and had a positive correlation with the levels of AFB1-DNA 
adducts, indicating the potency as biomarkers for AFB1-related HCC prognosis 
and tumorigenesis of those two miRNAs [106, 107]. Further, polymorphisms in 
pre-miRNAs were investigated for the potential as risk factors or prognostic bio-
markers of AFB1-induced HCC in a large case-control hospital research in China, 
in which rs28599926 in miR-1268a was identified as one candidate [108]. Later, 
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several studies about the mechanisms underlying the signaling pathway involved 
in these processes were conducted. Liu et al. found that in vivo upregulation of 
rno-miR-34a-5p leads to cell cycle arrest by downregulating the expression of the 
cell cycle-related genes MET, CCNE2, and CCND1. It also facilitated p53 repair 
of DNA damage in the liver of AFB1-treated rats. Thus, miR-34a-5p might be 
considered as a sensitive biomarker of AFB1-induced DNA damage in the liver 
[107]. Zeng hypothesized that the dysfunction of a novel GSK-3b-C/EBPa-miR-122-
IGF-1R regulatory circuitry was the mechanism behind the development of HCC 
[109]. In vitro studies on different expression profiles of miRNAs identified several 
cancer-related microRNAs and the predicted target genes involved in cancer-related 
pathways. Zhu et al. found that upregulation of miR-34a might suppress the Wnt/β-
catenin signaling pathway in HepG2 cells anticipated by AFB1 [110]. Another 
functional studies revealed that miR-138-1* inhibited proliferation, colony forma-
tion, migration, and invasion of P50 B-2A13 cells and might affect AFB1-induced 
malignant transformation through targeting PDK1 [111].
The majority of these studies investigated the regulation of miRNAs. One 
study, however, reported the changes of lncRNA expression in AFB1-induced HCC 
formation. The upregulation of H19 gene encoding lncRNA was found to promote 
cell growth and invasion in human HepG2 cells after AFB1 treatment [112]. Since 
lncRNA is a novel hot spot of noncoding RNA researches, the information is lim-
ited. More detailed studies are required to establish the signaling pathway involved 
in this process to understand the mechanism.
4. Detoxification strategies
It is reported that carry-over of AFB1 as AFM1 in the milk of dairy cows has been 
established to range from 0.3 to 6.2% [113]. In consideration of this high prevalence 
of AFB1 in food, it is of great priority to find effective strategies to prevent or 
remove contamination in order to restore the safety and edibility of food products. 
Prevention of Aspergillus infection can stop the contamination from the source. The 
control strategies include the use of genetically altered crops that are resistant to 
Aspergillus and environmental stressors, pesticide usage, crop rotation, and timing 
of planting, together with proper drying, packaging, storage, and preservative/
pesticide usage to suppress fungal reproduction. These strategies however are not 
enough to fully inhibit contamination, so further postharvest techniques are being 
developed to detoxify contaminated foods. These then involve the knowledge of 
physical and chemical characteristics of AFB1. The characteristic frame of AFB1 is 
the fusion of a cyclopentenone ring to the lactone ring of the coumarin structure. 
The toxin favors polar organic solvents and is barely soluble in nonpolar solvents and 
slightly soluble in water. AFB1 remains stable even at high temperature (>100°C), 
so that regular thermal procession cannot detoxicate it during food manufacturing. 
This thermal stability makes a great obstacle in the reduction of aflatoxin in milk 
and dairy products, since the wild used sterilization such as pasteurization, etc. all 
belonging to thermal treatment. Other physical or chemical properties led to the 
development of other methods of decontamination in order to assure a good level 
of decontamination without disruption of the nutritional properties or safety of 
feed. Those strategies can be classified into physical treatment, biological treatment, 
chemical treatment, combination strategy, and sorbent additives.
Physical means of removing AFB1 from foods are most commonly heating 
comparatively to a higher temperature or for a longer time and irradiation using 
gamma (γ) rays. AFB1 is reported almost completely degraded at harsh heating 
temperatures as high as 160°C and above [114]. Prolonging of heating time and 
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additional humidity can help the detoxification [115]. However, such a strategy may 
disrupt the integrity of product after heating/roasting is complete. This advantage 
inhibits the popularity of the maximum temperature that can be used, resulting in 
incomplete removal of AFB1. The other most commonly reported physical decon-
tamination method is γ radiation. This technique has been widely tested in a variety 
of food substrates, with an average percent reduction of 65%. The fundamental 
of γ radiation is production of ionizing radiation. According to a recent study, the 
effective concentration ranged from 6 to 60 kGy [115].
Biological-based interventions have also been investigated for their potential 
in reducing AFB1 levels. Lact microbes such as lactobacillus, saccharomyces, 
cellulosimicrobium, and others have been identified to enzymatically convert 
aflatoxin, zearalenone, ochratoxin, patulin, fumonisin, deoxynivalenol, and T-2 
toxin to less toxic products [116]. The reduction averaged approximately 86% across 
recent studies. Despite microbe degradation, herbal extract incubation is another 
biological strategy. Dissolving AFB1 in aqueous extracts of various plant species 
is also highly effective. For example, according to the reported data, extracts from 
Adhatoda vasica Ness and Corymbia citriodora both achieved >95% degradation of 
AFB1 [117]. Treatment time using those two approaches however is very long, usu-
ally requiring several days to carry out [118]. It would allow an increasing efficiency 
of those processes by further identification of the active components responsible 
for the degradation. Therefore, the use of purified enzymes from various biologi-
cal sources has been investigated for AFB1 degradation potential. Those agents 
have included laccases, manganese peroxidase, and the recently identified Bacillus 
aflatoxin-degrading enzyme. The efficacy of these approaches has been high, but 
more information based on further practice on real food substrates is necessary. As 
is the case with all the biological control methods, the time of treatment is still long, 
taking several days to complete which may not be feasible in large-scale applications 
[119–121]. Another disadvantage lies in an uncertainty of the end products of the 
treatments, which makes the safety of treated foods hard to determine.
Chemical additives are also widely used to detoxify contaminated foods in the 
food industry. Acidification, including citric, lactic, tartaric, and hydrochloric acid, 
has shown high efficiency in reducing toxicity of AFB1-contaminated foods. These 
methods have been observed to have high reduction rate in less than 24 h even at 
room temperature. The conducting process is also simple, just requiring to soak 
contaminated foods in acidic solutions for a given amount of time [61, 122, 123]. 
Unlike biological degradation, the detoxification product of AFB1 in acid is AFB2a as 
mentioned above, which is widely recognized as a far less toxic metabolite of AFB1. 
On the other hand, ammoniation which refers to breaking down AFB1 in an alkaline 
environment is also effective in detoxification. When foods are treated with either 
gaseous or liquid ammonia (usually 1.5–2%), the degradation rate can sometimes 
reach above 99% in comparatively long time, ranging from 24 h to 15 days [124, 
125]. The degradation product due to ammoniation is a less mutagenic metabolite of 
AFB1, known as aflatoxin D1 (AFD1), formed through hydrolysis and decarboxyl-
ation, though risking a reversion back into AFB1 if reset in an acidified environment 
[126]. Finally, ozonation is another commonly used chemical control method. 
Ozonolysis at a concentration of 6–90 mg/L has been shown to quickly degrade 
AFB1 by 86.75% in as little as 20 min in wheat. Other recent studies have treatment 
time range from 30 min to 96 h, mostly under 180 min, and all have seen >65% 
reductions. Additionally, ozone has been investigated in a variety of foodstuffs, 
indicating a stable effectiveness and reliable safety [115, 127, 128]. According to an 
analysis of the breakdown products of AFB1 after ozonolysis by Diao et al., the moi-
eties responsible for mutagenicity disappeared, indicating that these products are 
likely less toxic, although it has not been verified using mutagenicity assays [115].
Aflatoxin B1 Occurrence, Detection and Toxicological Effects
10
All those methods mentioned above solely have had moderate to high success 
in reducing AFB1 levels; nevertheless, the highest efficacies are seen when they are 
combined with one another. The combination of ammonia and heat has been shown 
to drastically reduce treatment time from several days to 15–120 min and repeatedly 
manifested >99% reduction of AFB1 in a series of studies [129–131]. Proctor et al. 
reported that heating along with ozonation turned out to have reduced treatment 
time and lower effective temperature while remaining as high as 77% reduction 
of AFB1 in peanuts at 75°C after only 10 min [132]. Treatment of contaminated 
foods with alkaline substances (other than ammonia) along with heat is another 
effective method. Nixtamalization, the tortilla-making process employing heat and 
alkaline calcium hydroxide, has been shown to decrease AFB1 by approximately 84 
and 90% in two separate studies [133, 134]. The applications of high temperatures 
(80–120°C) together with acidification such as HCl, citric acid, and lactic acid were 
also reported to have high degrading potential (85–100%). The addition of citric 
acid can help degrade 98% of AFB1 at 100°C in 20 min [135–137]. The combination 
of heat and acidification is attractive with the fact that those two methods sepa-
rately have already been widely used in food manufacturing industry, so that no 
specialized or expensive equipment is needed additionally. A unique combination 
has recently been performed by Rushing and Selim where acidification has been 
used with heat and arginine. This causes AFB1 to form a stable pyrrole ring with the 
amino acid, which is completely non-genotoxic and inabsorbable across the intes-
tinal tract. This method was able to completely converse AFB1-contaminated corn 
in 20 min. This result advocates for adding amino acids to the previous acidification 
treatments to form stable, nontoxic forms of AFB1 [137].
Another unique approach to solving AFB1 contamination is the addition of 
sorbents to food. This method is different from the degradation methods because 
it prevents the hepatotoxic effects of AFB1 by acting as binding agents to prevent 
absorption of AFB1 across the intestinal tract after ingestion rather than destroying 
or reducing the amount of AFB1 in the food as mentioned above. Chlorophyllin 
and chlorophyll as the most well-studied of those agents were observed to reduce 
AFB1-DNA adduct by 37% in rainbow trout and in turn reduce tumor incidence 
by 77%, when added to the contaminated feed [138]. Simonich et al. reported that 
when AFB1-contaminated feed was added with chlorophyllin and chlorophyll, 
AFB1-DNA adducts, AFB1-albumin, and urinary AFM1 levels in rat reduced by 42, 
65, and 90% compared with 55, 51, and 92%, respectively. Accordingly, the tumor 
incidence in these rats was reduced by 74 and 77%, respectively [139]. Egner et al. 
found that, by introducing chlorophyllin into the diets of humans in high-risk 
areas for AFB1 exposure, AFB1-N7-guanine levels in those subjects reduced by 55% 
compared to that in individuals who were not fed with this agent [140]. In another 
clinical study, four volunteers were given a single dose of 30 ng of AFB1 with either 
the co-administration of chlorophyll and chlorophyllin or not. Results showed 
that chlorophyllin and chlorophyll reduced urinary AFM1 levels by 28 and 41%, 
respectively [140]. Those data above show that sorbents or binding agents in diets in 
high-risk areas can partially alleviate the toxic effects of AFB1.
Clay is another commonly studied enterosorbent. With a mechanism similar 
to that of chlorophyllin and chlorophyll, clays have been shown to protect against 
AFB1 toxicities in multiple animal models by reducing AFB1 absorption and reduc-
ing AFM1 levels in milk. NovaSil (a calcium montmorillonite clay) is particularly 
successful in reducing the toxic effects of aflatoxin-contaminated feed and AFB1 
biomarkers in humans [141]. In long-term animal study, no overt toxicities were 
observed when rats were fed up to 2.0% of NovaSil in their diet for 28 weeks, 
indicating the safety of using this substance [142]. In a clinical trial, Ghanaians 
in high risk for AFB1 exposure were given an oral bolus of placebo, low dose, or 
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high dose of NovaSil. Participants in the low and high dose had significantly lower 
AFB1 biomarkers such as urinary AFM1 and serum AFB1-albumin after a period 
of 3 months. Additionally, during the observation, only mild, infrequent adverse 
effects were reported (such as nausea, diarrhea, heartburn, and dizziness), and no 
significant side effects were monitored by evaluating liver, kidney, or hematological 
parameters of all the individuals [143, 144]. These results indicate that the addition 
of NovaSil into the diet can be a safe and effective method to reduce AFB1 toxicity.
5. Future direction and conclusions
In the past decade, several studies have emphasized the important role of 
AFB1 in public dietary health. The high frequency and levels of AFB1 recently 
found in food supplies of various countries, particularly in Africa and Asia, indi-
cate that exposure of populations to this toxin still remains largely uncontrolled. 
The toxin is then well known for its strong carcinogenesis potential. In fact, when 
further investigations were made, AFB1 was found to cause function feebleness of 
nearly all organs and systems. Furthermore, AFB1 has become an occupational haz-
ard for those working in the food industry, leading to some particularly high rates of 
exposure. Evidence that has been gathered over the last several decades has shown 
the clear carcinogenic effect of AFB1. Also, the negative effect of AFB1 on nutritive 
status, growth/development, and immune system function is becoming clearer.
So as to disrupt or reverse AFB1-related pathobiological process, it is necessary 
to have a better understanding of the mechanism of AFB1 toxicity. Instead of stating 
AFB1 impairment to individual organ, a further exploration into the genotoxicity and 
epigenetic toxicity should be more proper, which has become a future trend in novel 
toxicity testing. However, researches focus on the relationship between histone modi-
fications and AFB1 exposure, and the regulation of other noncoding RNAs except for 
miRNAs in AFB1 toxic mechanisms is rare. More effort is needed in related research. 
The network between epigenetic and genetic mechanisms in AFB1 toxicity needs 
further exploration, since genetic changes and epigenetic changes influence each 
other in most of the pathobiological process [92]. In addition, in the past few years, a 
variety of single-cell technologies have shed light on the extraordinary variability and 
accuracy of AFB1 toxicity. These technologies provide more opportunities to study 
the mechanism of AFB1 toxicity at the single-cell level, which is the central theme of 
recently raised concept precision toxicology [145].
In conclusion, AFB1 contamination remains an unneglectable threat to public 
health in developing countries. Its effect on malformation and other health prob-
lems may have been underestimated due to data deficiency. Despite the effective-
ness of existing detoxification methods mentioned above, those methods are far 
from being popularized. Perhaps over time, these methods will see increased usage 
in order to provide cleaner foods worldwide.
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